HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (aminosulfonyl)- 7- (ethanolamino)- 2,1,3- benzoxadiazole

structure in first source

Also Known As:

ABD-N

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - Oxadiazoles: 146
        4-(aminosulfonyl)-7-(ethanolamino)-2,1,3-benzoxadiazole: 1
Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - 4-(aminosulfonyl)-7-(ethanolamino)-2,1,3-benzoxadiazole: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - 4-(aminosulfonyl)-7-(ethanolamino)-2,1,3-benzoxadiazole: 1

Experts

1.	Behets, Geert J: 1 article (05/2003)
2.	Bervoets, An R J: 1 article (05/2003)
3.	D'Haese, Patrick C: 1 article (05/2003)
4.	Dams, Geert: 1 article (05/2003)
5.	De Broe, Marc E: 1 article (05/2003)
6.	Polenakovic, Momir H: 1 article (05/2003)
7.	Spasovski, Goce B: 1 article (05/2003)
8.	Van Hoof, Viviane O: 1 article (05/2003)
9.	Zafirovska, Katica: 1 article (05/2003)

Related Diseases

1.	Osteomalacia 05/01/2003 - "Significant (P < 0.005) differences between the five groups with ROD (ie, normal bone [N = 32], adynamic bone [ABD; N = 19], hyperparathyroidism [N = 8], osteomalacia [OM; N = 10], and mixed lesion [N = 15]) were noted for intact parathyroid hormone, total (TAP) and bone alkaline phosphatase (BAP), osteocalcin (OC), and serum calcium levels. "
2.	Hyperparathyroidism 05/01/2003 - "Significant (P < 0.005) differences between the five groups with ROD (ie, normal bone [N = 32], adynamic bone [ABD; N = 19], hyperparathyroidism [N = 8], osteomalacia [OM; N = 10], and mixed lesion [N = 15]) were noted for intact parathyroid hormone, total (TAP) and bone alkaline phosphatase (BAP), osteocalcin (OC), and serum calcium levels. "

Related Drugs and Biologics

1.	Osteocalcin
2.	Parathyroid Hormone (Parathormone)
3.	Calcium
4.	Alkaline Phosphatase